Kimia Farma Tbk PT
IDX:KAEF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Kimia Farma Tbk PT
Other Receivables
Kimia Farma Tbk PT
Other Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Other Receivables
Rp101.2B
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
17%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Other Receivables
Rp229.3B
|
CAGR 3-Years
38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Other Receivables
Rp245B
|
CAGR 3-Years
12%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Other Receivables
Rp54.1B
|
CAGR 3-Years
66%
|
CAGR 5-Years
34%
|
CAGR 10-Years
24%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Other Receivables
Rp319.8B
|
CAGR 3-Years
16%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Other Receivables
Rp5.2B
|
CAGR 3-Years
23%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
Kimia Farma Tbk PT
Glance View
PT Kimia Farma Tbk engages in the production and distribution of healthcare products. The company is headquartered in Jakarta, Dki Jakarta and currently employs 11,668 full-time employees. The company went IPO on 2001-07-04. The firm produces medical devices and chemical materials. The firm is also involved in producing vegetable oil, iodine, and salts. Its products include Glucokaf, Diazink, Oracef, Kifarox, Magacid Suspension, Magaside Chewable Tablets, Nitrocafe Retarded, Nitrocafe Retard Forte, Trinolon, Raistine, VAGIZOL, Neviral, Hiviral Tablet, Duviral, Codipront Cum Expectorant, RETHAPHYL SR, and SUPRAFLU. Its generic products include PETHIDIN Hcl, PARACETAMOL, Diclofenac Sodium, MEPHANAMIC ACID, ANTALGIN, ANTASIDE DOEN, PYRANTEL, ALBENDAZOLE, METRONIDAZOLE TABLET, NEO BLOOD ADDING TABLET, FERROUS SULOATE SYRUP, DIMENHYDRINATE, ACYCLOVIR, AMBROXOL HCL, CHLOROQUINE, CHLORPROMAZINE HCL, CODEIN, CLOPIDOGREL, ERGOTAMINE COFFEE, METHYLERGOMETRINE TABLET SALUTE, MELOXICAM, and Pherphenazine.
See Also
What is Kimia Farma Tbk PT's Other Receivables?
Other Receivables
101.2B
IDR
Based on the financial report for Dec 31, 2025, Kimia Farma Tbk PT's Other Receivables amounts to 101.2B IDR.
What is Kimia Farma Tbk PT's Other Receivables growth rate?
Other Receivables CAGR 10Y
17%
Over the last year, the Other Receivables growth was -46%. The average annual Other Receivables growth rates for Kimia Farma Tbk PT have been -44% over the past three years , -15% over the past five years , and 17% over the past ten years .
